Impact of intraprocedural antiplatelet therapy on stent patency and safety after emergent intracranial stenting in acute ischaemic stroke: insights from the RESISTANT registry
Francesco Diana, Ameer E Hassan, Santiago Ortega-Gutierrez, Samantha Miller et autres
INTRODUCTION: Emergent intracranial stenting (EIS) is increasingly employed in the context of the acute ischaemic stroke treatment, but requires intraprocedural antiplatelet therapy (APT), which may raise haemorrhagic risk. This study aimed to evaluate the safety and effectiveness of different APT regimens during …
es, it, us, ch, tr, pt, fr, tw (code pays fourni par la source)